Evidence map›Paper›PMID 28605403›Full record

ArticleBriefings in bioinformatics2018

Power and sample size calculations for high-throughput sequencing-based experiments.

Chung-I Li, David C Samuels, Ying-Yong Zhao, Yu Shyr, Yan Guo

Abstract read
In one paragraph

Article in Briefings in bioinformatics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Biomarker development for axial spondyloarthritis.Nature reviews. Rheumatology · 2020
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Chung-I LiDepartment of Statistics, National Cheng Kung University in Taiwan.
David C SamuelsDepartment of Molecular Physiology and Biophysics, Vanderbilt University, USA.
Ying-Yong ZhaoSchool of Life Sciences, Northwest University, China.
Yu ShyrDepartment of Biostatistics, Vanderbilt University, USA.
Yan GuoDepartment of Cancer Biology, Vanderbilt University.

Funding

Tumor Immunology and Microenvironment Research ProgramP30CA068485 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI MATTHEW J TYSKA · 1995 to 2026
$172.8M
Barrett's Esophagus Translational Research Network Coordinating Center (BETRNetCC)U24CA163056 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI SHYR, YU · 2017 to 2022
$2.1M
NCI NIH HHS P30 CA068485NCI NIH HHS U24 CA163056
6 · The paper itself

Abstract

Power/sample size (power) analysis estimates the likelihood of successfully finding the statistical significance in a data set. There has been a growing recognition of the importance of power analysis in the proper design of experiments. Power analysis is complex, yet necessary for the success of large studies. It is important to design a study that produces statistically accurate and reliable results. Power computation methods have been well established for both microarray-based gene expression studies and genotyping microarray-based genome-wide association studies. High-throughput sequencing (HTS) has greatly enhanced our ability to conduct biomedical studies at the highest possible resolution (per nucleotide). However, the complexity of power computations is much greater for sequencing data than for the simpler genotyping array data. Research on methods of power computations for HTS-based studies has been recently conducted but is not yet well known or widely used. In this article, we describe the power computation methods that are currently available for a range of HTS-based studies, including DNA sequencing, RNA-sequencing, microbiome sequencing and chromatin immunoprecipitation sequencing. Most importantly, we review the methods of power analysis for several types of sequencing data and guide the reader to the relevant methods for each data type.

Indexed as

Chromatin ImmunoprecipitationGenome-Wide Association StudyHeterozygoteHigh-Throughput Nucleotide SequencingHumansMicrobiotaMutationPoisson DistributionSequence Analysis, RNA

Identifiers

PMID28605403
PMCPMC6291796

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.